Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy

Liposome-like nanoarchitectures containing manganese ferrite nanoparticles covered or decorated with gold were developed for application in dual cancer therapy, combining chemotherapy and photothermia. The magnetic/plasmonic nanoparticles were characterized using XRD, UV/Visible absorption, HR-TEM,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irina S. R. Rio, Ana Rita O. Rodrigues, Juliana M. Rodrigues, Maria-João R. P. Queiroz, R. C. Calhelha, Isabel C. F. R. Ferreira, Bernardo G. Almeida, Ana Pires, André M. Pereira, João P. Araújo, Elisabete M. S. Castanheira, Paulo J. G. Coutinho
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/0777f1a3ee694dec82ebd2512c5b589d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0777f1a3ee694dec82ebd2512c5b589d
record_format dspace
spelling oai:doaj.org-article:0777f1a3ee694dec82ebd2512c5b589d2021-11-25T18:41:42ZMagnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy10.3390/pharmaceutics131119051999-4923https://doaj.org/article/0777f1a3ee694dec82ebd2512c5b589d2021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1905https://doaj.org/toc/1999-4923Liposome-like nanoarchitectures containing manganese ferrite nanoparticles covered or decorated with gold were developed for application in dual cancer therapy, combining chemotherapy and photothermia. The magnetic/plasmonic nanoparticles were characterized using XRD, UV/Visible absorption, HR-TEM, and SQUID, exhibiting superparamagnetic behavior at room temperature. The average size of the gold-decorated nanoparticles was 26.7 nm for MnFe<sub>2</sub>O<sub>4</sub> with 5–7 nm gold nanospheres. The average size of the core/shell nanoparticles was 28.8 nm for the magnetic core and around 4 nm for the gold shell. Two new potential antitumor fluorescent drugs, tricyclic lactones derivatives of thienopyridine, were loaded in these nanosystems with very high encapsulation efficiencies (higher than 98%). Assays in human tumor cell lines demonstrate that the nanocarriers do not release the antitumor compounds in the absence of irradiation. Moreover, the nanosystems do not cause any effect on the growth of primary (non-tumor) cells (with or without irradiation). The drug-loaded systems containing the core/shell magnetic/plasmonic nanoparticles efficiently inhibit the growth of tumor cells when irradiated with red light, making them suitable for a triggered release promoted by irradiation.Irina S. R. RioAna Rita O. RodriguesJuliana M. RodriguesMaria-João R. P. QueirozR. C. CalhelhaIsabel C. F. R. FerreiraBernardo G. AlmeidaAna PiresAndré M. PereiraJoão P. AraújoElisabete M. S. CastanheiraPaulo J. G. CoutinhoMDPI AGarticlemanganese ferrite/gold nanoparticlesmagnetoliposomesnew antitumor drugsthienopyridine derivativescombined cancer therapyPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1905, p 1905 (2021)
institution DOAJ
collection DOAJ
language EN
topic manganese ferrite/gold nanoparticles
magnetoliposomes
new antitumor drugs
thienopyridine derivatives
combined cancer therapy
Pharmacy and materia medica
RS1-441
spellingShingle manganese ferrite/gold nanoparticles
magnetoliposomes
new antitumor drugs
thienopyridine derivatives
combined cancer therapy
Pharmacy and materia medica
RS1-441
Irina S. R. Rio
Ana Rita O. Rodrigues
Juliana M. Rodrigues
Maria-João R. P. Queiroz
R. C. Calhelha
Isabel C. F. R. Ferreira
Bernardo G. Almeida
Ana Pires
André M. Pereira
João P. Araújo
Elisabete M. S. Castanheira
Paulo J. G. Coutinho
Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy
description Liposome-like nanoarchitectures containing manganese ferrite nanoparticles covered or decorated with gold were developed for application in dual cancer therapy, combining chemotherapy and photothermia. The magnetic/plasmonic nanoparticles were characterized using XRD, UV/Visible absorption, HR-TEM, and SQUID, exhibiting superparamagnetic behavior at room temperature. The average size of the gold-decorated nanoparticles was 26.7 nm for MnFe<sub>2</sub>O<sub>4</sub> with 5–7 nm gold nanospheres. The average size of the core/shell nanoparticles was 28.8 nm for the magnetic core and around 4 nm for the gold shell. Two new potential antitumor fluorescent drugs, tricyclic lactones derivatives of thienopyridine, were loaded in these nanosystems with very high encapsulation efficiencies (higher than 98%). Assays in human tumor cell lines demonstrate that the nanocarriers do not release the antitumor compounds in the absence of irradiation. Moreover, the nanosystems do not cause any effect on the growth of primary (non-tumor) cells (with or without irradiation). The drug-loaded systems containing the core/shell magnetic/plasmonic nanoparticles efficiently inhibit the growth of tumor cells when irradiated with red light, making them suitable for a triggered release promoted by irradiation.
format article
author Irina S. R. Rio
Ana Rita O. Rodrigues
Juliana M. Rodrigues
Maria-João R. P. Queiroz
R. C. Calhelha
Isabel C. F. R. Ferreira
Bernardo G. Almeida
Ana Pires
André M. Pereira
João P. Araújo
Elisabete M. S. Castanheira
Paulo J. G. Coutinho
author_facet Irina S. R. Rio
Ana Rita O. Rodrigues
Juliana M. Rodrigues
Maria-João R. P. Queiroz
R. C. Calhelha
Isabel C. F. R. Ferreira
Bernardo G. Almeida
Ana Pires
André M. Pereira
João P. Araújo
Elisabete M. S. Castanheira
Paulo J. G. Coutinho
author_sort Irina S. R. Rio
title Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy
title_short Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy
title_full Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy
title_fullStr Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy
title_full_unstemmed Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy
title_sort magnetoliposomes based on magnetic/plasmonic nanoparticles loaded with tricyclic lactones for combined cancer therapy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/0777f1a3ee694dec82ebd2512c5b589d
work_keys_str_mv AT irinasrrio magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT anaritaorodrigues magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT julianamrodrigues magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT mariajoaorpqueiroz magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT rccalhelha magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT isabelcfrferreira magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT bernardogalmeida magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT anapires magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT andrempereira magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT joaoparaujo magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT elisabetemscastanheira magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
AT paulojgcoutinho magnetoliposomesbasedonmagneticplasmonicnanoparticlesloadedwithtricycliclactonesforcombinedcancertherapy
_version_ 1718410754646867968